Home > Compound List > Product Information
Pilsicainide hydrochloride_Molecular_structure_CAS_)
Click picture or here to close

Pilsicainide hydrochloride

Catalog No. P0026 Name Sigma Aldrich
CAS Number Website http://www.sigmaaldrich.com
M. F. C17H25ClN2O Telephone 1-800-521-8956
M. W. 308.8462 Fax
Purity ≥98% (HPLC) Email
Storage Chembase ID: 154642

SYNONYMS

IUPAC name
N-(2,6-dimethylphenyl)-2-(hexahydro-1H-pyrrolizin-7a-yl)acetamide hydrochloride
IUPAC Traditional name
pilsicainide hydrochloride
Synonyms
Pilzicainide hydrochloride
N-(2,6-Dimethylphenyl)tetrahydro-1H-pyrrolizine-7a(5H)-acetamide hydrochloride
SUN 1165

DATABASE IDS

MDL Number MFCD00903769

PROPERTIES

Empirical Formula (Hill Notation) C17H24N2O · xHCl
Purity ≥98% (HPLC)
Apperance white to beige powder
Solubility deionized water: >5 mg/mL
GHS Pictograms GHS07
GHS Signal Word Warning
GHS Hazard statements H302
European Hazard Symbols Harmful Harmful (Xn)
MSDS Link Download
RID/ADR UN 2811 6.1/PG 3
Risk Statements 22
Storage Temperature room temp
Hazard Class 6.1
UN Number 2811
Packing Group 3
German water hazard class 3

DETAILS

Description (English)
Biochem/physiol Actions
Pilsicainide hydrochloride is a pure sodium channel blocker and an open channel blocker of Na+1 channels. Pilsicainide was defined as a pure sodium channel blocker. The compound is classified as a class Ic antiarrhythmic drug, and was originally developed in Japan. Similar to Lidocaine, Pilsicainide binds to open channels, but slowly. Pilsicainide is capable of selectively blocking the late currents in the mutant Na(+) channels that show dominant abnormal burst openings such as in δKPQ mutants. The compound is used to induce Brugada syndrome (BS) in animal models.
Description (简体中文)
Biochem/physiol Actions
Pilsicainide hydrochloride is a pure sodium channel blocker and an open channel blocker of Na+1 channels. Pilsicainide was defined as a pure sodium channel blocker. The compound is classified as a class Ic antiarrhythmic drug, and was originally developed in Japan. Similar to Lidocaine, Pilsicainide binds to open channels, but slowly. Pilsicainide is capable of selectively blocking the late currents in the mutant Na(+) channels that show dominant abnormal burst openings such as in δKPQ mutants. The compound is used to induce Brugada syndrome (BS) in animal models.

REFERENCES